Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237364 · ClinicalTrials.gov registry record · Early Phase 1
Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)
A Early Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT03237364: Completed Early Phase 1 study, sponsored by Hal C Charles.
NCT03237364 is a Early Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 7 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03237364, a Early Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as an exogenous inert contrast agent to image the airway spaces in subjects with suspected lung disease, post deployment in Iraq and Afghanistan. This is an open label proof of concept study expanding on work here at Duke.
Primary Outcome
Fraction of lung with slow filling compartments compared to historic norms.
Interventions
- DIAGNOSTIC_TEST Perfluorinated Gas/Oxygen Mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-19 |
| Est. Completion | 2020-02-28 |
| Phase | Early Phase 1 |
What the finished NCT03237364 record still lists
NCT03237364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Perfluorinated Gas/Oxygen Mixture is the first listed.
NCT03237364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03237364 about?
NCT03237364 is a clinical study titled "Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)". The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as an exogenous inert contrast agent to image the airway spaces in subjects with suspected lung disease, post deployment in Iraq and Afghanistan. This is an open label p...
What is the current status of trial NCT03237364?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2017-08-19. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03237364?
The interventions under investigation include: Perfluorinated Gas/Oxygen Mixture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03237364?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03237364's enrollment target sits among peer trials
7 1825th of 2000 higher than 156 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI